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from Teichtahl et al., http://dx.doi.org/10.1186/s13075-016-0945-xWith much interest we read the recent paper by
Teichtahl et al. [1], who gave novel insight into the asso-
ciation between disc degeneration and intervertebral disc
height. The current golden standard, the Pfirrmann
Score, has a good internal validity. However, its subject-
ive nature, low discriminative power, and moderate rela-
tion to physiological and clinical parameters have
inspired many investigators to search for a better alter-
native. We support this enthusiastically, as there is a
great need for a measure with higher clinical relevance.
Loss of water is a feature of disc degeneration. There-
fore, disc height or volume is a simple parameter to
monitor discal changes in large groups. The data shown
in this research, however, suggest that this measure is
probably not a clinically relevant parameter. Figure 2b
of Teichtahl et al. [1] shows that an individual with a
corrected disc height of 11 mm easily fits within one
standard deviation of the averages found for Pfirrmann
grades 2, 3, and 4, leaving no option to discriminate be-
tween mild-to-severe degeneration. Moreover, it is im-
portant to recognize that disc height is a temporary
state of the discus, strongly dependent on loading his-
tory [2] and therefore highly variable within subjects.
Over 20 % average disc height variation within the
same day has been reported [3], comparable with two
Pfirrmann grades on a single day. The high inter-
subject and intra-subject variation emphasizes the limi-
tations for using this measure as a relevant parameter,* Correspondence: th.smit@vumc.nl
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This may explain why Videman et al. [4] found that
disc height explained only 7 % of the variance in low-
back pain.
To improve the current golden standard, the relation
to physiological parameters can be used as a benchmark.
We would like to highlight that several continuous mag-
netic resonance imaging measures have already been de-
veloped, some of which have shown encouraging
relations to biomechanical properties and biochemical
content, in addition to significant associations with the
Pfirrmann Score. Examples of these measures are T1ρ
[5], T2* mapping, and quantitative T2 mapping (e.g.,
[6]). Evaluating new measures in this way is a promising
development, because only with stable and relevant mea-
sures can the relation between disc degeneration and
low-back pain be investigated properly.
In conclusion, there is a great need for relevant mea-
sures of disc degeneration. However, the results of this
study indicate that disc height should not be used as a
singular measure for disc degeneration.Competing interests
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